UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Current pharmaceutical design, 2007-07, Vol.13 (20), p.2057-2073

2007

Volltextzugriff (PDF)

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

Matrix biology, 2010-07, Vol.29 (6), p.442-452

2010

Volltextzugriff (PDF)

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

Clinical cancer research, 2011-03, Vol.17 (6), p.1382-1393

2011

Volltextzugriff (PDF)

Pentosan polysulfate to control hepcidin expression in vitro and in vivo

Biochemical pharmacology, 2020-05, Vol.175, p.113867-113867, Article 113867

2020

Volltextzugriff (PDF)

The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin

Thrombosis research, 2014-05, Vol.133 (5), p.855-862

2014

Volltextzugriff (PDF)

Old and new applications of non-anticoagulant heparin

International journal of cardiology, 2016-06, Vol.212, p.S14-S21

2016

Volltextzugriff (PDF)

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer

Frontiers in immunology, 2023-08, Vol.14, p.1173634

2023

Volltextzugriff (PDF)

Human (α2→6) and Avian (α2→3) Sialylated Receptors of Influenza A Virus Show Distinct Conformations and Dynamics in Solution

Biochemistry (Easton), 2013-10, Vol.52 (41), p.7217-7230

2013

Volltextzugriff (PDF)

Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting

The Journal of biological chemistry, 2005-04, Vol.280 (13), p.12103-12113

2005

Volltextzugriff (PDF)

Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential

Clinical and applied thrombosis/hemostasis, 2017-10, Vol.23 (7), p.725-734

2017

Volltextzugriff (PDF)

Orthogonal analytical approaches to detect potential contaminants in heparin

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (40), p.16956-16961

2009

Volltextzugriff (PDF)

Structural features of low-molecular-weight heparins affecting their affinity to antithrombin

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.865-873

2009

Volltextzugriff (PDF)

Nuclear Magnetic Resonance and Molecular Dynamics Simulation of the Interaction between Recognition Protein H7 of the Novel Influenza Virus H7N9 and Glycan Cell Surface Receptors

Biochemistry (Easton), 2016-12, Vol.55 (48), p.6605-6616

2016

Volltextzugriff (PDF)

Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin

PloS one, 2017-06, Vol.12 (6), p.e0180206-e0180206

2017

Volltextzugriff (PDF)

Heparin centenary – an ever-young life-saving drug

International journal of cardiology, 2016-06, Vol.212, p.S1-S4

2016

Volltextzugriff (PDF)

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

Blood, 2007-09, Vol.110 (6), p.2041-2048

2007

Volltextzugriff (PDF)

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides

Frontiers in immunology, 2020-04, Vol.11, p.732-732

2020

Volltextzugriff (PDF)

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

The FASEB journal, 2005-02, Vol.19 (2), p.211-221

2005

Volltextzugriff (PDF)

SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition

Frontiers in medicine, 2019-04, Vol.6, p.78-78

2019

Volltextzugriff (PDF)

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin

Frontiers in pharmacology, 2016-01, Vol.6, p.316-316

2016

Volltextzugriff (PDF)

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives

Thrombosis research, 2012-05, Vol.129 (5), p.603-610

2012

Volltextzugriff (PDF)

Non-Anticoagulant Heparins as Heparanase Inhibitors

Advances in experimental medicine and biology, 2020-01, Vol.1221, p.493-522

2020

Volltextzugriff (PDF)

The tainted heparin story: an update

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.907-911

2009

Volltextzugriff (PDF)

Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis

Frontiers in cell and developmental biology, 2022-03, Vol.10, p.798088-798088

2022

Volltextzugriff (PDF)

Heparanase, heparin and the coagulation system in cancer progression

Thrombosis research, 2007, Vol.120, p.S112-S120

2007

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(103)
Buchkapitel
(4)

Sprache

Englisch
(107)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer

SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis

Pentosan polysulfate to control hepcidin expression in vitro and in vivo

The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin

Old and new applications of non-anticoagulant heparin

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer

Human (α2→6) and Avian (α2→3) Sialylated Receptors of Influenza A Virus Show Distinct Conformations and Dynamics in Solution

Modulation of the Heparanase-inhibiting Activity of Heparin through Selective Desulfation, Graded N-Acetylation, and Glycol Splitting

Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential

Orthogonal analytical approaches to detect potential contaminants in heparin

Structural features of low-molecular-weight heparins affecting their affinity to antithrombin

Nuclear Magnetic Resonance and Molecular Dynamics Simulation of the Interaction between Recognition Protein H7 of the Novel Influenza Virus H7N9 and Glycan Cell Surface Receptors

Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin

Heparin centenary – an ever-young life-saving drug

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides

Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models

SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition

High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin

The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives

Non-Anticoagulant Heparins as Heparanase Inhibitors

The tainted heparin story: an update

Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis

Heparanase, heparin and the coagulation system in cancer progression

Aktive Filter

Suchergebnisse filtern